Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01528696 · ClinicalTrials.gov registry record · Phase 4

Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section

A Phase 4 study, sponsored by University of Michigan.

Terminated
Registry status
Phase 4
Development phase
37
Enrollment target

NCT01528696 is a Phase 4 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 37 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01528696, a Phase 4 study, was terminated before completion, sponsored by University of Michigan.

TERMINATED
Registry status
Phase 4
Development phase
37 participants
Enrollment target

Study Summary

Obese patients undergoing cesarean section are at high risk for wound complications, which occur in approximately 20% of patients. This is a randomized controlled trial designed to determine whether the risk for wound-related complications can be reduced by covering the incision with a silver-impregnated dressing in the postoperative period.

Interventions

  • DEVICE Silverlon
  • DEVICE Standard Dressing

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2012-02
Est. Completion 2013-01
Phase Phase 4

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT01528696

The ClinicalTrials.gov registry entry for NCT01528696 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Silverlon is the first listed.

NCT01528696 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01528696 about?

NCT01528696 is a clinical study titled "Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section". Obese patients undergoing cesarean section are at high risk for wound complications, which occur in approximately 20% of patients. This is a randomized controlled trial designed to determine whether the risk for wound-related complications can be reduced by covering the incision with a silver-impreg...

What is the current status of trial NCT01528696?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2012-02. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01528696?

The interventions under investigation include: Silverlon (DEVICE), Standard Dressing (DEVICE).

Who is sponsoring clinical trial NCT01528696?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.